EUVIMEDEUVIMED entdecken
Crossref

Modified Xuan-Bi-Qing-Ying decoction alleviates septic liver injury by regulating autophagy and apoptosis via HIF-1α signaling pathway

Jing Yan, Yifeng Pan, Zhu Liu, Yulin Chen, Kai Hu, Yuanyuan Liu, Guangyao Wang, Liqun Li, Sheng Xie

Tissue and Cell · 2026

DOI: 10.1016/j.tice.2025.103299 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Tissue and Cell, 2026. Verfasst von Jing Yan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Guangxi University of Chinese Medicine, Nanning, Guangxi 530200, China. Hauptthemen laut MEDLINE: Drugs, Chinese Herbal, Apoptosis, Signal Transduction, Hypoxia-Inducible Factor 1, alpha Subunit. Die Arbeit nennt 73 Literaturangaben. Gefördert von: Guangxi Key Research and Development Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Xuan-Bi-Qing-Ying Decoction (XBQYD), a Traditional Chinese Medicine (TCM) formula modified based on clinical experience, has demonstrated efficacy and safety in the treatment of septic liver injury (SLI). METHODS: The absorbed components of XBQYD were characterized in vivo using LC-MS/MS. A rat model of septic liver injury (SLI) was then established by cecal ligation and puncture. To evaluate the preventive efficacy of XBQYD, rats were pretreated with the formula for seven days prior to injury induction. Subsequently, we evaluated liver histopathology (HE staining), measured serum inflammatory cytokines (IL-1β, IL-6, TNF-α), oxidative stress markers (MDA, SOD) with commercial kits, and assessed liver function via biochemical analysis. To investigate the mechanism, network pharmacology was combined with Mendelian randomization (MR) analysis, which identified HIF1A as a core predicted target. Based on this prediction, the influence of XBQYD pretreatment on the HIF‑1α pathway was measured in liver tissue at both mRNA and protein levels, along with its downstream effects on autophagy and apoptosis. Finally, molecular docking and dynamics simulations were used to investigate potential direct interactions between key XBQYD constituents and HIF-1α. RESULTS: A total of 22 bioactive components derived from XBQYD were identified in vivo. In SLI rats, pretreatment with XBQYD significantly mitigated liver histological damage, decreased pro-inflammatory cytokine levels and oxidative stress, and restored liver function. Network pharmacology revealed 233 intersecting targets of XBQYD and SLI. KEGG and PPI analyses highlighted the HIF-1 signaling pathway and 50 core targets, including HIF1A. MR analysis confirmed that HIF1A may increase the risk of sepsis and sepsis-related 28-day mortality. This preventive effect was associated with the inhibition of the HIF-1α pathway activation by XBQYD pretreatment, which correlated with enhanced autophagy and suppressed apoptosis. Molecular docking and dynamics simulations demonstrated stable interactions between key XBQYD constituents (Quercetin, Delphinidin, and Azaleatin) and HIF-1α. CONCLUSION: Our study demonstrates that pretreatment with XBQYD exerts a preventive effect against SLI in rats by inhibiting the HIF-1α signaling pathway. These findings provide a mechanistic basis for considering XBQYD as a potential preventive strategy for SLI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drugs, Chinese HerbalApoptosisSignal TransductionHypoxia-Inducible Factor 1, alpha SubunitAutophagySepsisLiverAnimalsMaleRatsRats, Sprague-DawleyMolecular Docking SimulationOxidative StressCytokines

Stichwörter der Autor:innen

HIF-1α signaling pathwayXuan-Bi-Qing-Ying Decoction (XBQYD)autophagynetwork pharmacologyseptic liver injury (SLI)

Substanzen

Drugs, Chinese HerbalHypoxia-Inducible Factor 1, alpha SubunitHif1a protein, ratCytokines

Autor:innen und Institutionen

  • Graduate School of Guangxi University of Chinese Medicine, Nanning, Guangxi 530200, China.
  • The Eighth Clinical Medical College of Guangzhou University of Chinese Medicine, Foshan, Guangdong 528000, China.
  • The First Affiliated Hospital of Guangxi University of Chinese Medicine, Nanning, Guangxi 530001, China.
  • The First Affiliated Hospital of Guangxi University of Chinese Medicine, Nanning, Guangxi 530001, China. Electronic address: 2215713788@qq.com.
  • The First Affiliated Hospital of Guangxi University of Chinese Medicine, Nanning, Guangxi 530001, China. Electronic address: xiesheng2018tougao@163.com.

Förderung

  • Guangxi Key Research and Development Program

Zitieren

APA

Yan, J., Pan, Y., Liu, Z., Chen, Y., Hu, K., Liu, Y., Wang, G., Li, L., & Xie, S. (2026). Modified Xuan-Bi-Qing-Ying decoction alleviates septic liver injury by regulating autophagy and apoptosis via HIF-1α signaling pathway. Tissue and Cell. https://doi.org/10.1016/j.tice.2025.103299

Vancouver

Yan J, Pan Y, Liu Z, Chen Y, Hu K, Liu Y, et al. Modified Xuan-Bi-Qing-Ying decoction alleviates septic liver injury by regulating autophagy and apoptosis via HIF-1α signaling pathway. Tissue and Cell. 2026. doi:10.1016/j.tice.2025.103299

BibTeX
@article{Yan2026,
  author = {Yan, Jing and Pan, Yifeng and Liu, Zhu and Chen, Yulin and Hu, Kai and Liu, Yuanyuan and Wang, Guangyao and Li, Liqun and Xie, Sheng},
  title = {Modified Xuan-Bi-Qing-Ying decoction alleviates septic liver injury by regulating autophagy and apoptosis via HIF-1α signaling pathway},
  journal = {Tissue and Cell},
  year = {2026},
  doi = {10.1016/j.tice.2025.103299}
}
Kostenlos starten →